Perrigo gets FDA approval for generic Mycolog II cream
SILVER SPRING, Md. — Perrigo has received Food and Drug Administration approval for its generic of Mycolog II cream (nystatin and triamcinolone acetonide cream, 100,000 units/g and 1 mg/g) cream, the company announced Wednesday.
“This final approval and anticipated launch exemplify Perrigo's ongoing commitment to developing quality, high value alternatives in important treatment categories.” Perrigo EVP and president Rx pharmaceuticals John Wesolowski said. “The Rx team continues to leverage our extended topicals strategy and development capabilities to deliver Quality Affordable Healthcare Products to customers, consumers and families around the world.”
The drug is indicated to treat cutaneous candidiasis. It had a U.S. market size of $93 million for the 12 months ended June 2017. The company said it anticipates a launch in the fourth quarter of 2017.
Diplomat now dispensing prescription-free naloxone
FLINT, Mich. — Diplomat Pharmacy has joined the ranks of pharmacy chains providing naloxone to its patients without requiring a prescription. The company on Tuesday announced that it would be offering the opioid overdose antidote at its Flint retail pharmacy.
“Protecting the health and safety of our patients is what we do,” Diplomat EVP operations Gary Rice. “We are committed to providing access to lifesaving medication like naloxone in the communities we serve.”
The Centers for Disease Control and Prevention estimate that more than 1,000 Americans are treated in emergency departments for misusing prescription opioids daily.